INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 47 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $70,383 | +28.6% | 334,360 | -2.3% | 0.00% | – |
Q1 2023 | $54,730 | -85.6% | 342,060 | -50.0% | 0.00% | – |
Q4 2022 | $379,686 | -6.7% | 684,120 | +100.0% | 0.00% | – |
Q3 2022 | $407,000 | +102.5% | 342,060 | +7.5% | 0.00% | – |
Q2 2022 | $201,000 | -90.6% | 318,160 | -83.1% | 0.00% | – |
Q1 2022 | $2,149,000 | -46.9% | 1,884,979 | +4.8% | 0.00% | – |
Q4 2021 | $4,048,000 | -30.7% | 1,798,973 | +5.4% | 0.00% | – |
Q3 2021 | $5,839,000 | +40.4% | 1,707,221 | +22.8% | 0.00% | – |
Q2 2021 | $4,158,000 | +2135.5% | 1,390,699 | +2314.9% | 0.00% | – |
Q1 2021 | $186,000 | +59.0% | 57,589 | +4.2% | 0.00% | – |
Q4 2020 | $117,000 | +80.0% | 55,289 | 0.0% | 0.00% | – |
Q3 2020 | $65,000 | +30.0% | 55,289 | 0.0% | 0.00% | – |
Q2 2020 | $50,000 | +8.7% | 55,289 | 0.0% | 0.00% | – |
Q1 2020 | $46,000 | -13.2% | 55,289 | 0.0% | 0.00% | – |
Q4 2019 | $53,000 | -7.0% | 55,289 | 0.0% | 0.00% | – |
Q3 2019 | $57,000 | -43.0% | 55,289 | 0.0% | 0.00% | – |
Q2 2019 | $100,000 | -3.8% | 55,289 | 0.0% | 0.00% | – |
Q1 2019 | $104,000 | +60.0% | 55,289 | 0.0% | 0.00% | – |
Q4 2018 | $65,000 | -56.7% | 55,289 | 0.0% | 0.00% | – |
Q3 2018 | $150,000 | +31.6% | 55,289 | -7.2% | 0.00% | – |
Q2 2018 | $114,000 | -8.8% | 59,605 | 0.0% | 0.00% | – |
Q1 2018 | $125,000 | +3.3% | 59,605 | 0.0% | 0.00% | – |
Q4 2017 | $121,000 | +36.0% | 59,605 | -11.6% | 0.00% | – |
Q3 2017 | $89,000 | -84.5% | 67,405 | -81.6% | 0.00% | – |
Q2 2017 | $574,000 | -84.1% | 367,176 | -67.1% | 0.00% | – |
Q1 2017 | $3,605,000 | +170.0% | 1,116,117 | +12.8% | 0.00% | – |
Q4 2016 | $1,335,000 | -17.1% | 989,060 | -4.1% | 0.00% | – |
Q3 2016 | $1,610,000 | +17.8% | 1,031,377 | +0.5% | 0.00% | – |
Q2 2016 | $1,367,000 | -70.1% | 1,026,314 | +18.3% | 0.00% | – |
Q1 2016 | $4,569,000 | -72.2% | 867,627 | -58.5% | 0.00% | -100.0% |
Q4 2015 | $16,407,000 | -48.0% | 2,090,153 | -44.0% | 0.00% | -50.0% |
Q3 2015 | $31,531,000 | -11.5% | 3,731,632 | +14.6% | 0.00% | 0.0% |
Q2 2015 | $35,647,000 | +8.5% | 3,255,703 | +38.6% | 0.00% | +33.3% |
Q1 2015 | $32,846,000 | +12.5% | 2,349,630 | +35.9% | 0.00% | 0.0% |
Q4 2014 | $29,205,000 | +25.9% | 1,729,006 | +0.0% | 0.00% | +50.0% |
Q3 2014 | $23,200,000 | -7.5% | 1,728,984 | -12.1% | 0.00% | -33.3% |
Q2 2014 | $25,070,000 | +0.8% | 1,967,894 | -5.9% | 0.00% | 0.0% |
Q1 2014 | $24,873,000 | -56.9% | 2,091,949 | -25.6% | 0.00% | -25.0% |
Q4 2013 | $57,696,000 | +93.0% | 2,812,306 | +64.1% | 0.00% | 0.0% |
Q3 2013 | $29,895,000 | +4.5% | 1,713,344 | -2.7% | 0.00% | 0.0% |
Q2 2013 | $28,612,000 | – | 1,760,487 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |